Cargando…

Circulating miRNAs are generic and versatile therapeutic monitoring biomarkers in muscular dystrophies

The development of medical approaches requires preclinical and clinical trials for assessment of therapeutic efficacy. Such evaluation entails the use of biomarkers, which provide information on the response to the therapeutic intervention. One newly-proposed class of biomarkers is the microRNA (miR...

Descripción completa

Detalles Bibliográficos
Autores principales:	Israeli, David, Poupiot, Jérôme, Amor, Fatima, Charton, Karine, Lostal, William, Jeanson-Leh, Laurence, Richard, Isabelle
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4914855/ https://www.ncbi.nlm.nih.gov/pubmed/27323895 http://dx.doi.org/10.1038/srep28097

Ejemplares similares

Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy
por: Vu Hong, Ai, et al.
Publicado: (2022)

Distinctive Serum miRNA Profile in Mouse Models of Striated Muscular Pathologies
por: Vignier, Nicolas, et al.
Publicado: (2013)

Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy
por: Amor, Fatima, et al.
Publicado: (2021)

Circulating Muscle-specific miRNAs in Duchenne Muscular Dystrophy Patients
por: Li, Xihua, et al.
Publicado: (2014)

Assessment of Therapeutic Potential of a Dual AAV Approach for Duchenne Muscular Dystrophy
por: Albini, Sonia, et al.
Publicado: (2023)

Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy
por: Bourg, Nathalie, et al.
Publicado: (2022)

A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy
por: Vu Hong, Ai, et al.
Publicado: (2021)

An AAV-SGCG Dose-Response Study in a γ-Sarcoglycanopathy Mouse Model in the Context of Mechanical Stress
por: Israeli, David, et al.
Publicado: (2019)

miRNAs as serum biomarkers for Duchenne muscular dystrophy
por: Cacchiarelli, Davide, et al.
Publicado: (2011)

Towards a piRNA prediction using multiple kernel fusion and support vector machine
por: Brayet, Jocelyn, et al.
Publicado: (2014)

Identification of circulating miRNAs differentially expressed in patients with Limb-girdle, Duchenne or facioscapulohumeral muscular dystrophies
por: García-Giménez, José Luis, et al.
Publicado: (2022)

Serum proteomic profiling reveals fragments of MYOM3 as potential biomarkers for monitoring the outcome of therapeutic interventions in muscular dystrophies
por: Rouillon, Jérémy, et al.
Publicado: (2015)

A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome
por: Blandin, Gaëlle, et al.
Publicado: (2013)

Circulating Biomarkers for Duchenne Muscular Dystrophy
por: Aartsma-Rus, Annemieke, et al.
Publicado: (2015)

A comparison of AAV strategies distinguishes overlapping vectors for efficient systemic delivery of the 6.2 kb Dysferlin coding sequence
por: Pryadkina, Marina, et al.
Publicado: (2015)

MiRNAs and Muscle Regeneration: Therapeutic Targets in Duchenne Muscular Dystrophy
por: Aránega, Amelia Eva, et al.
Publicado: (2021)

Novel miRNA Biomarkers for Patients With Duchenne Muscular Dystrophy
por: Meng, Qi, et al.
Publicado: (2022)

Circulating Biomarkers in Muscular Dystrophies: Disease and Therapy Monitoring
por: Koutsoulidou, Andrie, et al.
Publicado: (2020)

miRNA Profiling for Early Detection and Treatment of Duchenne Muscular Dystrophy
por: Hrach, Heather C., et al.
Publicado: (2019)

Longitudinal Study of Three microRNAs in Duchenne Muscular Dystrophy and Becker Muscular Dystrophy
por: Trifunov, Selena, et al.
Publicado: (2020)

MiRNAs, Myostatin, and Muscle MRI Imaging as Biomarkers of Clinical Features in Becker Muscular Dystrophy
por: Marozzo, Roberta, et al.
Publicado: (2020)

miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy
por: Sanson, M., et al.
Publicado: (2020)

Saying NO to muscular dystrophy
por: Dove, Alan W.
Publicado: (2001)

Fatigue in muscular dystrophies
por: Angelini, Corrado, et al.
Publicado: (2012)

Cardiac Dysrhythmias, Cardiomyopathy and Muscular Dystrophy in Patients with Emery-Dreifuss Muscular Dystrophy and Limb-Girdle Muscular Dystrophy Type 1B
por: Hong, Jong-Seo, et al.
Publicado: (2005)

Facioscapulohumeral muscular dystrophy: Are telomeres the end of the story?
por: Stadler, Guido, et al.
Publicado: (2013)

Noncoding RNAs: Emerging Players in Muscular Dystrophies
por: Falcone, Germana, et al.
Publicado: (2014)

Proteomics of Muscle Microdialysates Identifies Potential Circulating Biomarkers in Facioscapulohumeral Muscular Dystrophy
por: Corasolla Carregari, Victor, et al.
Publicado: (2020)

Genetic Patterns of Selected Muscular Dystrophies in the Muscular Dystrophy Surveillance, Tracking, and Research Network
por: Kang, Peter B., et al.
Publicado: (2023)

Characteristics of Japanese Patients with Becker Muscular Dystrophy and Intermediate Muscular Dystrophy in a Japanese National Registry of Muscular Dystrophy (Remudy): Heterogeneity and Clinical Variation
por: Mori-Yoshimura, Madoka, et al.
Publicado: (2018)

Comparative proteomic analyses of Duchenne muscular dystrophy and Becker muscular dystrophy muscles: changes contributing to preserve muscle function in Becker muscular dystrophy patients
por: Capitanio, Daniele, et al.
Publicado: (2020)

Identification of cardiomyopathy associated circulating miRNA biomarkers in patients with muscular dystrophy using a complementary cardiovascular magnetic resonance and plasma profiling approach
por: Becker, Svetlana, et al.
Publicado: (2016)

Identification of Cardiomyopathy-Associated Circulating miRNA Biomarkers in Muscular Dystrophy Female Carriers Using a Complementary Cardiac Imaging and Plasma Profiling Approach
por: Florian, Anca, et al.
Publicado: (2018)

Studies of pseudohypertrophic muscular dystrophy
por: Bonsett, Charles A., 1921-
Publicado: (1969)

Autonomic regulation in muscular dystrophy
por: Angelini, Corrado, et al.
Publicado: (2013)

Autonomic regulation in muscular dystrophy
por: Sabharwal, Rasna
Publicado: (2014)

Improving the course of muscular dystrophy?
por: NIGRO, VINCENZO
Publicado: (2012)

Survival in Duchenne muscular dystrophy
por: RALL, SUSANNE, et al.
Publicado: (2012)

Muscle MRI in muscular dystrophies
por: Díaz-Manera, Jordi, et al.
Publicado: (2015)

Therapeutic advances in muscular dystrophy
por: Leung, Doris G, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_oehalcd5tm3tpojr21qoe7ip0f